| 0 |
ATYPICAL DOSE RESPONSE RELATIONSHIP |
1 |
0.5000 |
| 1 |
ORTHOSTATIC HEADACHE |
2 |
0.1250 |
| 2 |
PEPTIC ULCER HELICOBACTER |
1 |
0.0526 |
| 3 |
PERSISTENT POSTURAL-PERCEPTUAL DIZZINESS |
2 |
0.0513 |
| 4 |
MEDICAL DEVICE SITE PRURITUS |
1 |
0.0370 |
| 5 |
HEPATOBILIARY PROCEDURAL COMPLICATION |
1 |
0.0357 |
| 6 |
INFUSION SITE HYPERSENSITIVITY |
4 |
0.0333 |
| 7 |
VIIITH NERVE INJURY |
2 |
0.0294 |
| 8 |
DIABETIC GLAUCOMA |
1 |
0.0278 |
| 9 |
INFUSION SITE IRRITATION |
33 |
0.0257 |
| 10 |
INFUSION SITE MASS |
23 |
0.0212 |
| 11 |
BLOOD GLUCOSE FALSE POSITIVE |
1 |
0.0208 |
| 12 |
INFUSION SITE PAIN |
266 |
0.0206 |
| 13 |
PRODUCT REGIMEN CONFUSION |
1 |
0.0192 |
| 14 |
PANCREATOGENOUS DIABETES |
1 |
0.0154 |
| 15 |
GASTROINTESTINAL NEUROENDOCRINE TUMOUR |
1 |
0.0154 |
| 16 |
INFUSION SITE DISCOMFORT |
15 |
0.0145 |
| 17 |
ACCESSORY AURICLE |
1 |
0.0143 |
| 18 |
APPLICATION SITE FOLLICULITIS |
1 |
0.0139 |
| 19 |
INFUSION SITE INDURATION |
18 |
0.0121 |
| 20 |
ADMINISTRATION SITE INFLAMMATION |
1 |
0.0111 |
| 21 |
ADMINISTRATION SITE INDURATION |
1 |
0.0111 |
| 22 |
INFUSION SITE ULCER |
1 |
0.0109 |
| 23 |
EYE OPACITY |
1 |
0.0109 |
| 24 |
DIABETIC WOUND |
1 |
0.0108 |
| 25 |
INFUSION SITE PRURITUS |
33 |
0.0104 |
| 26 |
INFUSION SITE URTICARIA |
7 |
0.0104 |
| 27 |
HYPERTELORISM |
1 |
0.0101 |
| 28 |
INFUSION SITE RASH |
12 |
0.0087 |
| 29 |
INFUSION SITE SCAB |
1 |
0.0081 |
| 30 |
INFUSION SITE VESICLES |
4 |
0.0076 |
| 31 |
NEUROPROSTHESIS IMPLANTATION |
1 |
0.0072 |
| 32 |
THERAPEUTIC RESPONSE DELAYED |
20 |
0.0071 |
| 33 |
FALLOPIAN TUBE CANCER |
1 |
0.0069 |
| 34 |
GALLBLADDER OEDEMA |
2 |
0.0068 |
| 35 |
INFUSION SITE SCAR |
3 |
0.0068 |
| 36 |
INFUSION SITE BRUISING |
14 |
0.0065 |
| 37 |
IMMUNE-MEDIATED NEUROPATHY |
1 |
0.0065 |
| 38 |
INFUSION SITE HAEMORRHAGE |
21 |
0.0064 |
| 39 |
INFUSION SITE ERYTHEMA |
53 |
0.0063 |
| 40 |
INFUSION SITE INFLAMMATION |
4 |
0.0057 |
| 41 |
SUBCUTANEOUS DRUG ABSORPTION IMPAIRED |
3 |
0.0053 |
| 42 |
CERVIX HAEMORRHAGE UTERINE |
1 |
0.0052 |
| 43 |
CATHETER SITE INDURATION |
1 |
0.0052 |
| 44 |
CORTISOL ABNORMAL |
1 |
0.0050 |
| 45 |
INFUSION SITE REACTION |
15 |
0.0050 |
| 46 |
HEART VALVE CALCIFICATION |
1 |
0.0050 |
| 47 |
DELUSIONAL PERCEPTION |
2 |
0.0048 |
| 48 |
BACTERIAL DIARRHOEA |
1 |
0.0047 |
| 49 |
HYPERINSULINAEMIC HYPOGLYCAEMIA |
1 |
0.0045 |
| 50 |
INSULIN RESISTANCE |
9 |
0.0043 |
| 51 |
PUNCTURE SITE PAIN |
1 |
0.0043 |
| 52 |
PILONIDAL DISEASE |
1 |
0.0042 |
| 53 |
INFUSION SITE ABSCESS |
2 |
0.0040 |
| 54 |
ACETONAEMIA |
1 |
0.0040 |
| 55 |
SPINAL INSTABILITY |
1 |
0.0039 |
| 56 |
DRAIN PLACEMENT |
1 |
0.0039 |
| 57 |
ACCIDENTAL UNDERDOSE |
55 |
0.0038 |
| 58 |
EPIRETINAL MEMBRANE |
1 |
0.0036 |
| 59 |
CHOLESTEATOMA |
1 |
0.0036 |
| 60 |
MEDICAL DEVICE SITE PAIN |
2 |
0.0036 |
| 61 |
DIABETIC GANGRENE |
1 |
0.0035 |
| 62 |
LENS DISORDER |
1 |
0.0035 |
| 63 |
LARGE FOR DATES BABY |
3 |
0.0034 |
| 64 |
INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM |
1 |
0.0033 |
| 65 |
MALABSORPTION FROM INJECTION SITE |
1 |
0.0032 |
| 66 |
INFUSION SITE NODULE |
3 |
0.0031 |
| 67 |
NEUROPATHIC ARTHROPATHY |
2 |
0.0031 |
| 68 |
ADMINISTRATION SITE SWELLING |
1 |
0.0031 |
| 69 |
BLOOD GLUCOSE ABNORMAL |
56 |
0.0030 |
| 70 |
BLOOD GLUCOSE INCREASED |
566 |
0.0030 |
| 71 |
MEDULLARY THYROID CANCER |
1 |
0.0029 |
| 72 |
STIFF PERSON SYNDROME |
1 |
0.0029 |
| 73 |
TIME PERCEPTION ALTERED |
1 |
0.0028 |
| 74 |
PERIODIC LIMB MOVEMENT DISORDER |
1 |
0.0027 |
| 75 |
DIABETIC KETOSIS |
1 |
0.0026 |
| 76 |
COLON CANCER STAGE III |
1 |
0.0026 |
| 77 |
ALLERGIC COUGH |
2 |
0.0026 |
| 78 |
HYPOGLYCAEMIC ENCEPHALOPATHY |
1 |
0.0026 |
| 79 |
PANCREATOLITHIASIS |
1 |
0.0025 |
| 80 |
ACOUSTIC NEUROMA |
1 |
0.0024 |
| 81 |
HYDROTHORAX |
2 |
0.0024 |
| 82 |
INCORRECT PRODUCT DOSAGE FORM ADMINISTERED |
1 |
0.0024 |
| 83 |
BLOOD HOMOCYSTEINE INCREASED |
1 |
0.0023 |
| 84 |
ABDOMINAL LYMPHADENOPATHY |
2 |
0.0023 |
| 85 |
OSTOMY BAG PLACEMENT |
1 |
0.0022 |
| 86 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
10 |
0.0022 |
| 87 |
PREGNANCY TEST FALSE POSITIVE |
1 |
0.0021 |
| 88 |
BLOOD GLUCOSE DECREASED |
103 |
0.0021 |
| 89 |
INJECTION SITE SCAR |
6 |
0.0021 |
| 90 |
SHOCK HYPOGLYCAEMIC |
1 |
0.0021 |
| 91 |
WRONG PATIENT RECEIVED PRODUCT |
6 |
0.0020 |
| 92 |
DIABETIC RETINAL OEDEMA |
1 |
0.0020 |
| 93 |
INFUSION SITE SWELLING |
12 |
0.0019 |
| 94 |
BLOOD GASES ABNORMAL |
1 |
0.0019 |
| 95 |
HYPERTROPHY |
1 |
0.0018 |
| 96 |
SUPERFICIAL INJURY OF EYE |
2 |
0.0018 |
| 97 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
46 |
0.0018 |
| 98 |
PRESBYOPIA |
1 |
0.0018 |
| 99 |
BLOOD GLUCOSE FLUCTUATION |
19 |
0.0017 |
| 100 |
COLON CANCER STAGE IV |
1 |
0.0017 |
| 101 |
RETINAL ISCHAEMIA |
1 |
0.0016 |
| 102 |
WRONG PRODUCT ADMINISTERED |
11 |
0.0016 |
| 103 |
VITAMIN D INCREASED |
1 |
0.0016 |
| 104 |
PSOAS ABSCESS |
1 |
0.0016 |
| 105 |
MONOCLONAL GAMMOPATHY |
1 |
0.0016 |
| 106 |
PRODUCT STORAGE ISSUE |
6 |
0.0016 |
| 107 |
HIV TEST POSITIVE |
1 |
0.0015 |
| 108 |
CUTANEOUS SYMPTOM |
1 |
0.0015 |
| 109 |
MONOCYTE PERCENTAGE INCREASED |
1 |
0.0014 |
| 110 |
INJECTION SITE INFLAMMATION |
7 |
0.0014 |
| 111 |
DIABETIC ULCER |
1 |
0.0014 |
| 112 |
DYSLALIA |
1 |
0.0014 |
| 113 |
MYASTHENIC SYNDROME |
1 |
0.0013 |
| 114 |
INFUSION SITE INFECTION |
3 |
0.0013 |
| 115 |
BLOOD KETONE BODY INCREASED |
1 |
0.0013 |
| 116 |
MEDICAL DEVICE SITE DISCOMFORT |
1 |
0.0012 |
| 117 |
PROCEDURAL NAUSEA |
1 |
0.0012 |
| 118 |
GLYCOSYLATED HAEMOGLOBIN DECREASED |
2 |
0.0012 |
| 119 |
WRONG DOSE |
3 |
0.0012 |
| 120 |
REACTION TO PRESERVATIVES |
1 |
0.0012 |
| 121 |
ACNE PUSTULAR |
1 |
0.0012 |
| 122 |
CIRCADIAN RHYTHM SLEEP DISORDER |
1 |
0.0012 |
| 123 |
KETOACIDOSIS |
9 |
0.0012 |
| 124 |
INFECTED BITE |
1 |
0.0012 |
| 125 |
ENZYME LEVEL INCREASED |
1 |
0.0012 |
| 126 |
INTENTIONAL DEVICE USE ISSUE |
1 |
0.0012 |
| 127 |
MYCOTIC ALLERGY |
1 |
0.0012 |
| 128 |
CRANIOSYNOSTOSIS |
1 |
0.0012 |
| 129 |
URGE INCONTINENCE |
1 |
0.0011 |
| 130 |
ARTERIAL STENOSIS |
1 |
0.0011 |
| 131 |
INCORRECT PRODUCT FORMULATION ADMINISTERED |
1 |
0.0011 |
| 132 |
INJECTION SITE IRRITATION |
14 |
0.0011 |
| 133 |
ABULIA |
1 |
0.0011 |
| 134 |
RETINOPATHY |
4 |
0.0011 |
| 135 |
PRODUCT AFTER TASTE |
1 |
0.0010 |
| 136 |
INJECTION SITE DISCOMFORT |
11 |
0.0010 |
| 137 |
HYPERGLYCAEMIA |
38 |
0.0010 |
| 138 |
HYPOGLYCAEMIC UNCONSCIOUSNESS |
2 |
0.0010 |
| 139 |
MUCOSAL DISORDER |
1 |
0.0010 |
| 140 |
EYELID PAIN |
2 |
0.0010 |
| 141 |
TRIGGER FINGER |
4 |
0.0010 |
| 142 |
GASTRIC PH DECREASED |
1 |
0.0010 |
| 143 |
FULMINANT TYPE 1 DIABETES MELLITUS |
1 |
0.0010 |
| 144 |
INJECTION SITE HYPERSENSITIVITY |
3 |
0.0010 |
| 145 |
URETEROLITHIASIS |
1 |
0.0010 |
| 146 |
SINUSITIS BACTERIAL |
1 |
0.0009 |
| 147 |
CARPAL TUNNEL DECOMPRESSION |
1 |
0.0009 |
| 148 |
LIPODYSTROPHY ACQUIRED |
2 |
0.0009 |
| 149 |
NEUROMYOPATHY |
1 |
0.0009 |
| 150 |
VASCULAR CALCIFICATION |
1 |
0.0009 |
| 151 |
PANCREATIC MASS |
1 |
0.0009 |
| 152 |
IDIOPATHIC URTICARIA |
1 |
0.0009 |
| 153 |
KETOSIS |
1 |
0.0009 |
| 154 |
POST PROCEDURAL SWELLING |
1 |
0.0009 |
| 155 |
HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME |
1 |
0.0009 |
| 156 |
OLIGOHYDRAMNIOS |
3 |
0.0009 |
| 157 |
GASTROINTESTINAL ULCER HAEMORRHAGE |
1 |
0.0009 |
| 158 |
HYPOGLYCAEMIA |
43 |
0.0009 |
| 159 |
DIABETIC RETINOPATHY |
3 |
0.0009 |
| 160 |
MYOPIA |
2 |
0.0008 |
| 161 |
DYSPLASIA |
1 |
0.0008 |
| 162 |
REFLUX GASTRITIS |
1 |
0.0008 |
| 163 |
INFUSION SITE WARMTH |
1 |
0.0008 |
| 164 |
DEVICE INFUSION ISSUE |
2 |
0.0008 |
| 165 |
INTERVERTEBRAL DISC OPERATION |
1 |
0.0008 |
| 166 |
SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT |
1 |
0.0008 |
| 167 |
INJECTION SITE ABSCESS |
2 |
0.0008 |
| 168 |
ALLERGY TO CHEMICALS |
1 |
0.0008 |
| 169 |
NEUTROPHIL PERCENTAGE INCREASED |
1 |
0.0008 |
| 170 |
HYPERAESTHESIA TEETH |
1 |
0.0008 |
| 171 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
160 |
0.0008 |
| 172 |
PHYSICAL DECONDITIONING |
2 |
0.0008 |
| 173 |
INTERCEPTED PRODUCT SELECTION ERROR |
1 |
0.0008 |
| 174 |
COUNTERFEIT PRODUCT ADMINISTERED |
1 |
0.0008 |
| 175 |
MACULAR HOLE |
1 |
0.0007 |
| 176 |
LYMPHOCYTE PERCENTAGE DECREASED |
1 |
0.0007 |
| 177 |
INJECTION SITE PAIN |
224 |
0.0007 |
| 178 |
BILIARY TRACT DISORDER |
1 |
0.0007 |
| 179 |
NEOVASCULAR AGE-RELATED MACULAR DEGENERATION |
1 |
0.0007 |
| 180 |
CEREBRAL THROMBOSIS |
2 |
0.0007 |
| 181 |
CONNECTIVE TISSUE DISORDER |
1 |
0.0007 |
| 182 |
PANCREATIC CARCINOMA METASTATIC |
2 |
0.0007 |
| 183 |
CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY |
1 |
0.0007 |
| 184 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
2 |
0.0007 |
| 185 |
RED BLOOD CELL COUNT ABNORMAL |
1 |
0.0007 |
| 186 |
COCCYDYNIA |
1 |
0.0007 |
| 187 |
DIABETES MELLITUS INADEQUATE CONTROL |
12 |
0.0007 |
| 188 |
CHOLANGIOCARCINOMA |
1 |
0.0007 |
| 189 |
HYPERCAPNIA |
2 |
0.0007 |
| 190 |
EXPIRED PRODUCT ADMINISTERED |
22 |
0.0007 |
| 191 |
INCORRECT DOSE ADMINISTERED |
148 |
0.0006 |
| 192 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
14 |
0.0006 |
| 193 |
HUNGER |
9 |
0.0006 |
| 194 |
HYPOTONIA NEONATAL |
1 |
0.0006 |
| 195 |
SKIN REACTION |
9 |
0.0006 |
| 196 |
TRANSCRIPTION MEDICATION ERROR |
1 |
0.0006 |
| 197 |
PRE-ECLAMPSIA |
3 |
0.0006 |
| 198 |
COLON CANCER METASTATIC |
1 |
0.0006 |
| 199 |
HYPOGLYCAEMIA NEONATAL |
1 |
0.0006 |
| 200 |
OPTIC ATROPHY |
1 |
0.0006 |
| 201 |
DIABETIC NEUROPATHY |
3 |
0.0006 |
| 202 |
INTERCEPTED PRODUCT DISPENSING ERROR |
1 |
0.0006 |
| 203 |
HEPATIC FIBROSIS |
2 |
0.0006 |
| 204 |
FOETAL DEATH |
3 |
0.0006 |
| 205 |
HYPOPITUITARISM |
1 |
0.0006 |
| 206 |
PSEUDOMONAL SEPSIS |
1 |
0.0006 |
| 207 |
INFUSION SITE DISCHARGE |
1 |
0.0006 |
| 208 |
DRUG MONITORING PROCEDURE NOT PERFORMED |
1 |
0.0006 |
| 209 |
HAEMORRHAGE |
57 |
0.0005 |
| 210 |
OESOPHAGEAL SPASM |
1 |
0.0005 |
| 211 |
INJECTION SITE INJURY |
3 |
0.0005 |
| 212 |
NASAL OBSTRUCTION |
1 |
0.0005 |
| 213 |
INFECTED SKIN ULCER |
1 |
0.0005 |
| 214 |
AUTOIMMUNE THYROIDITIS |
2 |
0.0005 |
| 215 |
ADRENAL DISORDER |
1 |
0.0005 |
| 216 |
ATROPHY |
1 |
0.0005 |
| 217 |
INJECTION SITE MASS |
19 |
0.0005 |
| 218 |
IMMUNE-MEDIATED HEPATIC DISORDER |
1 |
0.0005 |
| 219 |
PHARYNGEAL SWELLING |
5 |
0.0005 |
| 220 |
SKIN ODOUR ABNORMAL |
2 |
0.0005 |
| 221 |
VISUAL IMPAIRMENT |
63 |
0.0005 |
| 222 |
DRUG DELIVERY SYSTEM ISSUE |
1 |
0.0005 |
| 223 |
ALLERGIC REACTION TO EXCIPIENT |
1 |
0.0005 |
| 224 |
OESOPHAGEAL CANDIDIASIS |
2 |
0.0005 |
| 225 |
DIABETIC KETOACIDOSIS |
12 |
0.0005 |
| 226 |
TYPE 1 DIABETES MELLITUS |
3 |
0.0005 |
| 227 |
PERIPHERAL VENOUS DISEASE |
2 |
0.0005 |
| 228 |
GOITRE |
2 |
0.0005 |
| 229 |
VENOUS THROMBOSIS LIMB |
1 |
0.0005 |
| 230 |
DEVICE CONNECTION ISSUE |
1 |
0.0005 |
| 231 |
VASCULAR OCCLUSION |
1 |
0.0005 |
| 232 |
EYE CONTUSION |
1 |
0.0005 |
| 233 |
TONGUE DISCOMFORT |
2 |
0.0005 |
| 234 |
CARDIAC FAILURE CHRONIC |
2 |
0.0005 |
| 235 |
OCULOGYRIC CRISIS |
1 |
0.0005 |
| 236 |
GASTRIC BYPASS |
1 |
0.0005 |
| 237 |
LIMB MASS |
1 |
0.0005 |
| 238 |
THIRST |
8 |
0.0004 |
| 239 |
FEAR OF DEATH |
1 |
0.0004 |
| 240 |
GASTROINTESTINAL HYPOMOTILITY |
1 |
0.0004 |
| 241 |
PERIARTHRITIS |
1 |
0.0004 |
| 242 |
READING DISORDER |
1 |
0.0004 |
| 243 |
UTERINE DISORDER |
1 |
0.0004 |
| 244 |
INJECTION SITE BRUISING |
34 |
0.0004 |
| 245 |
INJECTION SITE RASH |
13 |
0.0004 |
| 246 |
RADIUS FRACTURE |
1 |
0.0004 |
| 247 |
GASTROINTESTINAL OBSTRUCTION |
1 |
0.0004 |
| 248 |
INCORRECT DOSAGE ADMINISTERED |
2 |
0.0004 |
| 249 |
HAEMATOLOGICAL INFECTION |
1 |
0.0004 |
| 250 |
INFREQUENT BOWEL MOVEMENTS |
1 |
0.0004 |
| 251 |
VASODILATATION |
1 |
0.0004 |
| 252 |
METASTASES TO PERITONEUM |
1 |
0.0004 |
| 253 |
RETINAL ARTERY OCCLUSION |
1 |
0.0004 |
| 254 |
PRODUCT CONTAMINATION PHYSICAL |
1 |
0.0004 |
| 255 |
APPENDICITIS PERFORATED |
1 |
0.0004 |
| 256 |
HAEMORRHAGE URINARY TRACT |
1 |
0.0004 |
| 257 |
INJECTION SITE REACTION |
27 |
0.0004 |
| 258 |
MENOPAUSE |
1 |
0.0004 |
| 259 |
INJECTION SITE HAEMORRHAGE |
31 |
0.0004 |
| 260 |
CATHETER SITE PAIN |
1 |
0.0004 |
| 261 |
RETINAL DISORDER |
1 |
0.0004 |
| 262 |
PULMONARY HAEMORRHAGE |
3 |
0.0004 |
| 263 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
1 |
0.0004 |
| 264 |
INJECTION SITE PRURITUS |
25 |
0.0004 |
| 265 |
LARYNGOSPASM |
1 |
0.0004 |
| 266 |
SKIN DISCOMFORT |
1 |
0.0004 |
| 267 |
EAR CONGESTION |
1 |
0.0004 |
| 268 |
IMPAIRED GASTRIC EMPTYING |
5 |
0.0004 |
| 269 |
PRODUCT STORAGE ERROR |
32 |
0.0004 |
| 270 |
THYROID NEOPLASM |
1 |
0.0004 |
| 271 |
CYSTIC FIBROSIS |
2 |
0.0004 |
| 272 |
HAEMATOLOGICAL MALIGNANCY |
1 |
0.0004 |
| 273 |
PNEUMATOSIS INTESTINALIS |
1 |
0.0004 |
| 274 |
FINE MOTOR SKILL DYSFUNCTION |
1 |
0.0003 |
| 275 |
ABORTION |
1 |
0.0003 |
| 276 |
FEELING OF BODY TEMPERATURE CHANGE |
2 |
0.0003 |
| 277 |
THYROIDITIS |
1 |
0.0003 |
| 278 |
CRANIOCEREBRAL INJURY |
1 |
0.0003 |
| 279 |
DISCOMFORT |
20 |
0.0003 |
| 280 |
DIABETIC FOOT |
1 |
0.0003 |
| 281 |
GENERALISED OEDEMA |
4 |
0.0003 |
| 282 |
PANCREATIC CARCINOMA STAGE IV |
1 |
0.0003 |
| 283 |
BREAST CANCER RECURRENT |
1 |
0.0003 |
| 284 |
PHOTOPSIA |
2 |
0.0003 |
| 285 |
BLADDER PAIN |
1 |
0.0003 |
| 286 |
SCIATICA |
5 |
0.0003 |
| 287 |
INCOHERENT |
2 |
0.0003 |
| 288 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
2 |
0.0003 |
| 289 |
HYPOVENTILATION |
1 |
0.0003 |
| 290 |
TENDON DISORDER |
2 |
0.0003 |
| 291 |
HYPOACUSIS |
13 |
0.0003 |
| 292 |
ELECTROCARDIOGRAM ST SEGMENT ELEVATION |
1 |
0.0003 |
| 293 |
LYME DISEASE |
1 |
0.0003 |
| 294 |
DRY THROAT |
3 |
0.0003 |
| 295 |
INJURY ASSOCIATED WITH DEVICE |
6 |
0.0003 |
| 296 |
APLASIA PURE RED CELL |
1 |
0.0003 |
| 297 |
CERVICAL VERTEBRAL FRACTURE |
1 |
0.0003 |
| 298 |
INJECTION SITE URTICARIA |
7 |
0.0003 |
| 299 |
BLINDNESS UNILATERAL |
4 |
0.0003 |
| 300 |
JAUNDICE CHOLESTATIC |
1 |
0.0003 |
| 301 |
INJECTION SITE ERYTHEMA |
35 |
0.0003 |
| 302 |
PRODUCT DISPENSING ERROR |
6 |
0.0003 |
| 303 |
FEELING DRUNK |
2 |
0.0003 |
| 304 |
HYPERACUSIS |
1 |
0.0003 |
| 305 |
FACE INJURY |
1 |
0.0003 |
| 306 |
PARANASAL SINUS HYPERSECRETION |
1 |
0.0003 |
| 307 |
ERUCTATION |
5 |
0.0003 |
| 308 |
PANIC DISORDER |
1 |
0.0003 |
| 309 |
THERAPEUTIC PRODUCT EFFECT VARIABLE |
1 |
0.0003 |
| 310 |
FAECES HARD |
1 |
0.0003 |
| 311 |
CERVIX CARCINOMA |
1 |
0.0003 |
| 312 |
ORAL INFECTION |
1 |
0.0003 |
| 313 |
WOUND SECRETION |
1 |
0.0003 |
| 314 |
PRODUCT ADMINISTRATION INTERRUPTED |
2 |
0.0003 |
| 315 |
EXPOSURE VIA BREAST MILK |
1 |
0.0003 |
| 316 |
CEREBRAL ATROPHY |
1 |
0.0003 |
| 317 |
HYPERPHAGIA |
1 |
0.0003 |
| 318 |
OBSESSIVE-COMPULSIVE DISORDER |
2 |
0.0002 |
| 319 |
ENURESIS |
1 |
0.0002 |
| 320 |
PRESYNCOPE |
6 |
0.0002 |
| 321 |
FEEDING DISORDER |
5 |
0.0002 |
| 322 |
MATERNAL EXPOSURE DURING BREAST FEEDING |
1 |
0.0002 |
| 323 |
DECUBITUS ULCER |
2 |
0.0002 |
| 324 |
HICCUPS |
2 |
0.0002 |
| 325 |
HYPERURICAEMIA |
1 |
0.0002 |
| 326 |
LEG AMPUTATION |
1 |
0.0002 |
| 327 |
PRODUCT DOSE OMISSION ISSUE |
71 |
0.0002 |
| 328 |
PULSELESS ELECTRICAL ACTIVITY |
1 |
0.0002 |
| 329 |
ABSCESS LIMB |
1 |
0.0002 |
| 330 |
PRODUCT DISPENSING ISSUE |
1 |
0.0002 |
| 331 |
STAPHYLOCOCCAL BACTERAEMIA |
1 |
0.0002 |
| 332 |
MELANOCYTIC NAEVUS |
1 |
0.0002 |
| 333 |
ABDOMINAL ABSCESS |
1 |
0.0002 |
| 334 |
FACIAL PAIN |
2 |
0.0002 |
| 335 |
VASCULAR DEVICE INFECTION |
1 |
0.0002 |
| 336 |
END STAGE RENAL DISEASE |
4 |
0.0002 |
| 337 |
CATARACT |
13 |
0.0002 |
| 338 |
RETINAL DETACHMENT |
2 |
0.0002 |
| 339 |
BLOOD CHOLESTEROL ABNORMAL |
1 |
0.0002 |
| 340 |
LOCALISED OEDEMA |
1 |
0.0002 |
| 341 |
RENAL FUNCTION TEST ABNORMAL |
1 |
0.0002 |
| 342 |
PERFORMANCE STATUS DECREASED |
1 |
0.0002 |
| 343 |
SEASONAL ALLERGY |
3 |
0.0002 |
| 344 |
SPINAL DISORDER |
2 |
0.0002 |
| 345 |
GESTATIONAL DIABETES |
1 |
0.0002 |
| 346 |
PARALYSIS |
3 |
0.0002 |
| 347 |
LIMB OPERATION |
1 |
0.0002 |
| 348 |
KIDNEY TRANSPLANT REJECTION |
1 |
0.0002 |
| 349 |
HUMERUS FRACTURE |
1 |
0.0002 |
| 350 |
GUILLAIN-BARRE SYNDROME |
1 |
0.0002 |
| 351 |
HORMONE LEVEL ABNORMAL |
1 |
0.0002 |
| 352 |
HEPATOMEGALY |
2 |
0.0002 |
| 353 |
PANCREATIC DISORDER |
1 |
0.0002 |
| 354 |
HYPERVOLAEMIA |
1 |
0.0002 |
| 355 |
APPLICATION SITE SWELLING |
1 |
0.0002 |
| 356 |
HYPERAMMONAEMIA |
1 |
0.0002 |
| 357 |
THYROID DISORDER |
3 |
0.0002 |
| 358 |
PERIPHERAL VASCULAR DISORDER |
1 |
0.0002 |
| 359 |
SKIN NECROSIS |
1 |
0.0002 |
| 360 |
SWOLLEN TONGUE |
6 |
0.0002 |
| 361 |
MALABSORPTION |
1 |
0.0002 |
| 362 |
PARTIAL SEIZURES |
1 |
0.0002 |
| 363 |
MATERNAL EXPOSURE DURING PREGNANCY |
17 |
0.0002 |
| 364 |
POOR QUALITY PRODUCT ADMINISTERED |
2 |
0.0002 |
| 365 |
OVERWEIGHT |
1 |
0.0002 |
| 366 |
PRODUCT DELIVERY MECHANISM ISSUE |
1 |
0.0002 |
| 367 |
INJECTION SITE DISCHARGE |
1 |
0.0002 |
| 368 |
BURNING SENSATION |
13 |
0.0002 |
| 369 |
MUSCLE TIGHTNESS |
3 |
0.0002 |
| 370 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
1 |
0.0002 |
| 371 |
ASTHENOPIA |
1 |
0.0002 |
| 372 |
INTESTINAL ISCHAEMIA |
1 |
0.0002 |
| 373 |
DEAFNESS UNILATERAL |
1 |
0.0002 |
| 374 |
MACULAR OEDEMA |
1 |
0.0002 |
| 375 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
3 |
0.0002 |
| 376 |
ILLNESS |
18 |
0.0002 |
| 377 |
MOUTH SWELLING |
1 |
0.0002 |
| 378 |
ENTEROCOLITIS |
1 |
0.0002 |
| 379 |
PANCREATIC CARCINOMA |
5 |
0.0002 |
| 380 |
METABOLIC DISORDER |
1 |
0.0002 |
| 381 |
VASCULITIS |
2 |
0.0002 |
| 382 |
DYSSTASIA |
5 |
0.0002 |
| 383 |
URINE ODOUR ABNORMAL |
1 |
0.0002 |
| 384 |
DRUG INEFFECTIVE |
224 |
0.0002 |
| 385 |
ATAXIA |
2 |
0.0002 |
| 386 |
CATARACT OPERATION |
1 |
0.0002 |
| 387 |
CHOLECYSTITIS |
2 |
0.0002 |
| 388 |
MACULAR DEGENERATION |
2 |
0.0002 |
| 389 |
OSTEOMYELITIS |
3 |
0.0002 |
| 390 |
MENISCUS INJURY |
1 |
0.0002 |
| 391 |
EYE SWELLING |
6 |
0.0002 |
| 392 |
INFUSION SITE EXTRAVASATION |
1 |
0.0002 |
| 393 |
INJECTION SITE DISCOLOURATION |
2 |
0.0002 |
| 394 |
SWELLING OF EYELID |
1 |
0.0002 |
| 395 |
BRAIN OEDEMA |
2 |
0.0002 |
| 396 |
CYSTITIS |
5 |
0.0002 |
| 397 |
FOREIGN BODY SENSATION IN EYES |
1 |
0.0002 |
| 398 |
INJECTION SITE SWELLING |
12 |
0.0002 |
| 399 |
HYPOPHAGIA |
4 |
0.0002 |
| 400 |
MYDRIASIS |
2 |
0.0002 |
| 401 |
CONTUSION |
15 |
0.0002 |
| 402 |
GLAUCOMA |
3 |
0.0002 |
| 403 |
POLYP |
1 |
0.0002 |
| 404 |
APPETITE DISORDER |
1 |
0.0002 |
| 405 |
THERAPEUTIC RESPONSE SHORTENED |
5 |
0.0002 |
| 406 |
COGNITIVE DISORDER |
7 |
0.0001 |
| 407 |
EYE HAEMORRHAGE |
2 |
0.0001 |
| 408 |
NEOPLASM MALIGNANT |
10 |
0.0001 |
| 409 |
TERMINAL STATE |
1 |
0.0001 |
| 410 |
LIMB INJURY |
4 |
0.0001 |
| 411 |
NEPHROTIC SYNDROME |
1 |
0.0001 |
| 412 |
ONYCHOCLASIS |
1 |
0.0001 |
| 413 |
RESPIRATION ABNORMAL |
1 |
0.0001 |
| 414 |
JOINT EFFUSION |
1 |
0.0001 |
| 415 |
LYMPHOEDEMA |
1 |
0.0001 |
| 416 |
ORAL DISCOMFORT |
2 |
0.0001 |
| 417 |
FORMICATION |
1 |
0.0001 |
| 418 |
COORDINATION ABNORMAL |
2 |
0.0001 |
| 419 |
EXTRASYSTOLES |
1 |
0.0001 |
| 420 |
DEMENTIA |
4 |
0.0001 |
| 421 |
MASS |
2 |
0.0001 |
| 422 |
WOUND |
4 |
0.0001 |
| 423 |
PULMONARY TOXICITY |
1 |
0.0001 |
| 424 |
HAND FRACTURE |
1 |
0.0001 |
| 425 |
RETCHING |
3 |
0.0001 |
| 426 |
PRODUCT SUPPLY ISSUE |
1 |
0.0001 |
| 427 |
PANIC REACTION |
1 |
0.0001 |
| 428 |
HYPOKINESIA |
2 |
0.0001 |
| 429 |
GASTROENTERITIS |
2 |
0.0001 |
| 430 |
ASCITES |
4 |
0.0001 |
| 431 |
INFLAMMATION |
7 |
0.0001 |
| 432 |
BLINDNESS TRANSIENT |
1 |
0.0001 |
| 433 |
SENSITIVE SKIN |
1 |
0.0001 |
| 434 |
LIVER DISORDER |
6 |
0.0001 |
| 435 |
CEREBRAL DISORDER |
1 |
0.0001 |
| 436 |
DRUG EFFECT LESS THAN EXPECTED |
2 |
0.0001 |
| 437 |
BLOOD POTASSIUM DECREASED |
4 |
0.0001 |
| 438 |
LOSS OF CONSCIOUSNESS |
17 |
0.0001 |
| 439 |
HEPATOCELLULAR CARCINOMA |
1 |
0.0001 |
| 440 |
SKIN IRRITATION |
6 |
0.0001 |
| 441 |
DIFFUSE LARGE B-CELL LYMPHOMA |
1 |
0.0001 |
| 442 |
ATRIOVENTRICULAR BLOCK |
1 |
0.0001 |
| 443 |
LIMB DISCOMFORT |
4 |
0.0001 |
| 444 |
ANKLE FRACTURE |
2 |
0.0001 |
| 445 |
LOW DENSITY LIPOPROTEIN INCREASED |
1 |
0.0001 |
| 446 |
DEVICE INFORMATION OUTPUT ISSUE |
1 |
0.0001 |
| 447 |
PRODUCT USE COMPLAINT |
2 |
0.0001 |
| 448 |
PNEUMOTHORAX |
2 |
0.0001 |
| 449 |
LOW BIRTH WEIGHT BABY |
1 |
0.0001 |
| 450 |
ULCER |
2 |
0.0001 |
| 451 |
HYPERHIDROSIS |
16 |
0.0001 |
| 452 |
EYE PAIN |
7 |
0.0001 |
| 453 |
LOCALISED INFECTION |
3 |
0.0001 |
| 454 |
STENT PLACEMENT |
1 |
0.0001 |
| 455 |
MYASTHENIA GRAVIS |
1 |
0.0001 |
| 456 |
FRUSTRATION TOLERANCE DECREASED |
1 |
0.0001 |
| 457 |
MUSCLE DISORDER |
1 |
0.0001 |
| 458 |
POST PROCEDURAL INFECTION |
1 |
0.0001 |
| 459 |
CHOLELITHIASIS |
4 |
0.0001 |
| 460 |
HYPERAESTHESIA |
1 |
0.0001 |
| 461 |
EYE DISORDER |
4 |
0.0001 |
| 462 |
ESCHERICHIA INFECTION |
1 |
0.0001 |
| 463 |
SPINAL COMPRESSION FRACTURE |
1 |
0.0001 |
| 464 |
LIP SWELLING |
4 |
0.0001 |
| 465 |
POLLAKIURIA |
5 |
0.0001 |
| 466 |
GAIT INABILITY |
4 |
0.0001 |
| 467 |
CIRCULATORY COLLAPSE |
2 |
0.0001 |
| 468 |
DRUG RESISTANCE |
3 |
0.0001 |
| 469 |
CARDIAC OPERATION |
1 |
0.0001 |
| 470 |
BLOOD MAGNESIUM DECREASED |
1 |
0.0001 |
| 471 |
NEUROPATHY PERIPHERAL |
11 |
0.0001 |
| 472 |
HYSTERECTOMY |
1 |
0.0001 |
| 473 |
THERAPEUTIC RESPONSE DECREASED |
7 |
0.0001 |
| 474 |
ORTHOSTATIC HYPOTENSION |
2 |
0.0001 |
| 475 |
JOINT STIFFNESS |
3 |
0.0001 |
| 476 |
DEVICE USE ISSUE |
2 |
0.0001 |
| 477 |
AMENORRHOEA |
2 |
0.0001 |
| 478 |
MOBILITY DECREASED |
8 |
0.0001 |
| 479 |
LOSS OF LIBIDO |
1 |
0.0001 |
| 480 |
HEAVY MENSTRUAL BLEEDING |
1 |
0.0001 |
| 481 |
HEART RATE INCREASED |
11 |
0.0001 |
| 482 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0001 |
| 483 |
OEDEMA |
6 |
0.0001 |
| 484 |
HIDRADENITIS |
1 |
0.0001 |
| 485 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
2 |
0.0001 |
| 486 |
INCREASED TENDENCY TO BRUISE |
1 |
0.0001 |
| 487 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
1 |
0.0001 |
| 488 |
NERVE COMPRESSION |
1 |
0.0001 |
| 489 |
NEPHROPATHY |
1 |
0.0001 |
| 490 |
DIARRHOEA HAEMORRHAGIC |
1 |
0.0001 |
| 491 |
PHOTOPHOBIA |
2 |
0.0001 |
| 492 |
ARTERIOSCLEROSIS |
1 |
0.0001 |
| 493 |
LEUKAEMIA |
1 |
0.0001 |
| 494 |
FOOT FRACTURE |
2 |
0.0001 |
| 495 |
POISONING DELIBERATE |
1 |
0.0001 |
| 496 |
EYE INFLAMMATION |
1 |
0.0001 |
| 497 |
SLEEP APNOEA SYNDROME |
2 |
0.0001 |
| 498 |
INCREASED APPETITE |
2 |
0.0001 |
| 499 |
SUPRAVENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 500 |
LOWER LIMB FRACTURE |
2 |
0.0001 |
| 501 |
AUTOIMMUNE DISORDER |
1 |
0.0001 |
| 502 |
VITAMIN D DEFICIENCY |
1 |
0.0001 |
| 503 |
COELIAC DISEASE |
1 |
0.0001 |
| 504 |
MEMORY IMPAIRMENT |
14 |
0.0001 |
| 505 |
VITREOUS FLOATERS |
1 |
0.0001 |
| 506 |
BODY TEMPERATURE DECREASED |
1 |
0.0001 |
| 507 |
UPPER LIMB FRACTURE |
2 |
0.0001 |
| 508 |
SPINAL FRACTURE |
2 |
0.0001 |
| 509 |
BRAIN INJURY |
1 |
0.0001 |
| 510 |
LACRIMATION INCREASED |
3 |
0.0001 |
| 511 |
EMPHYSEMA |
1 |
0.0001 |
| 512 |
EXTRA DOSE ADMINISTERED |
4 |
0.0001 |
| 513 |
TASTE DISORDER |
2 |
0.0001 |
| 514 |
EYELID PTOSIS |
1 |
0.0001 |
| 515 |
BODY TEMPERATURE INCREASED |
2 |
0.0001 |
| 516 |
INITIAL INSOMNIA |
1 |
0.0001 |
| 517 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
1 |
0.0001 |
| 518 |
TOOTH LOSS |
2 |
0.0001 |
| 519 |
SCRATCH |
1 |
0.0001 |
| 520 |
JOINT DISLOCATION |
1 |
0.0001 |
| 521 |
DEPRESSED MOOD |
5 |
0.0001 |
| 522 |
FULL BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 523 |
PHARYNGITIS STREPTOCOCCAL |
1 |
0.0001 |
| 524 |
BACK INJURY |
1 |
0.0001 |
| 525 |
CONSTIPATION |
20 |
0.0001 |
| 526 |
CLOSTRIDIUM DIFFICILE INFECTION |
2 |
0.0001 |
| 527 |
ASPIRATION |
1 |
0.0001 |
| 528 |
STAPHYLOCOCCAL INFECTION |
3 |
0.0001 |
| 529 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
2 |
0.0001 |
| 530 |
VENTRICULAR FIBRILLATION |
1 |
0.0001 |
| 531 |
NERVE INJURY |
1 |
0.0001 |
| 532 |
BLISTER |
5 |
0.0001 |
| 533 |
FISTULA |
1 |
0.0001 |
| 534 |
GAIT DISTURBANCE |
17 |
0.0001 |
| 535 |
ANGER |
3 |
0.0001 |
| 536 |
EYE INFECTION |
1 |
0.0001 |
| 537 |
DERMATITIS CONTACT |
1 |
0.0001 |
| 538 |
SCAB |
1 |
0.0001 |
| 539 |
NEOPLASM |
1 |
0.0001 |
| 540 |
GASTRIC HAEMORRHAGE |
1 |
0.0001 |
| 541 |
EYE IRRITATION |
5 |
0.0001 |
| 542 |
DEVICE USE ERROR |
3 |
0.0001 |
| 543 |
DRY MOUTH |
7 |
0.0001 |
| 544 |
RENAL DISORDER |
4 |
0.0001 |
| 545 |
SPINAL PAIN |
1 |
0.0001 |
| 546 |
SEXUAL DYSFUNCTION |
1 |
0.0001 |
| 547 |
NASAL CONGESTION |
5 |
0.0001 |
| 548 |
COVID-19 PNEUMONIA |
1 |
0.0001 |
| 549 |
BACTERAEMIA |
1 |
0.0001 |
| 550 |
PRODUCT PRESCRIBING ERROR |
2 |
0.0001 |
| 551 |
THYROID CANCER |
1 |
0.0001 |
| 552 |
MENTAL IMPAIRMENT |
2 |
0.0001 |
| 553 |
NOCTURIA |
1 |
0.0001 |
| 554 |
PANIC ATTACK |
3 |
0.0001 |
| 555 |
NEURALGIA |
2 |
0.0001 |
| 556 |
DYSURIA |
3 |
0.0001 |
| 557 |
GLOMERULAR FILTRATION RATE DECREASED |
1 |
0.0001 |
| 558 |
TENDON RUPTURE |
1 |
0.0001 |
| 559 |
BALANCE DISORDER |
7 |
0.0001 |
| 560 |
ABNORMAL WEIGHT GAIN |
1 |
0.0001 |
| 561 |
SEPSIS |
9 |
0.0001 |
| 562 |
PHARYNGITIS |
1 |
0.0001 |
| 563 |
CYST |
1 |
0.0001 |
| 564 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
2 |
0.0001 |
| 565 |
HAIR COLOUR CHANGES |
1 |
0.0001 |
| 566 |
VISION BLURRED |
11 |
0.0001 |
| 567 |
DYSPNOEA EXERTIONAL |
3 |
0.0001 |
| 568 |
COLITIS |
3 |
0.0001 |
| 569 |
HAEMATEMESIS |
2 |
0.0001 |
| 570 |
WEIGHT DECREASED |
22 |
0.0001 |
| 571 |
DIABETES MELLITUS |
6 |
0.0001 |
| 572 |
SINUSITIS |
8 |
0.0001 |
| 573 |
ERECTILE DYSFUNCTION |
2 |
0.0001 |
| 574 |
ROTATOR CUFF SYNDROME |
1 |
0.0001 |
| 575 |
DECREASED APPETITE |
18 |
0.0001 |
| 576 |
HAEMATOMA |
2 |
0.0001 |
| 577 |
INJECTION SITE INDURATION |
1 |
0.0001 |
| 578 |
DIPLOPIA |
2 |
0.0001 |
| 579 |
RESPIRATORY TRACT INFECTION |
2 |
0.0001 |
| 580 |
NODULE |
1 |
0.0001 |
| 581 |
VOMITING |
36 |
0.0001 |
| 582 |
BEDRIDDEN |
1 |
0.0001 |
| 583 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 584 |
PULMONARY CONGESTION |
1 |
0.0001 |
| 585 |
SARS-COV-2 TEST POSITIVE |
1 |
0.0001 |
| 586 |
BLOOD PRESSURE DECREASED |
5 |
0.0001 |
| 587 |
DIZZINESS |
37 |
0.0001 |
| 588 |
DISTURBANCE IN ATTENTION |
4 |
0.0001 |
| 589 |
BLINDNESS |
3 |
0.0001 |
| 590 |
PNEUMONITIS |
2 |
0.0001 |
| 591 |
MIGRAINE |
7 |
0.0001 |
| 592 |
DEVICE MECHANICAL ISSUE |
1 |
0.0001 |
| 593 |
OSTEOPOROSIS |
3 |
0.0001 |
| 594 |
PRURITUS |
28 |
0.0001 |
| 595 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
13 |
0.0001 |
| 596 |
PROCEDURAL PAIN |
2 |
0.0001 |
| 597 |
FEELING COLD |
2 |
0.0001 |
| 598 |
CARDIO-RESPIRATORY ARREST |
3 |
0.0001 |
| 599 |
ROAD TRAFFIC ACCIDENT |
3 |
0.0001 |
| 600 |
URTICARIA |
12 |
0.0001 |
| 601 |
RENAL IMPAIRMENT |
6 |
0.0001 |
| 602 |
CARPAL TUNNEL SYNDROME |
1 |
0.0001 |
| 603 |
PERIPHERAL SWELLING |
11 |
0.0001 |
| 604 |
DISSEMINATED INTRAVASCULAR COAGULATION |
1 |
0.0001 |
| 605 |
FEELING ABNORMAL |
17 |
0.0001 |
| 606 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
2 |
0.0001 |
| 607 |
HYPERSENSITIVITY |
13 |
0.0001 |
| 608 |
RED BLOOD CELL COUNT DECREASED |
2 |
0.0001 |
| 609 |
HYPERSOMNIA |
2 |
0.0001 |
| 610 |
SOMNOLENCE |
14 |
0.0001 |
| 611 |
VAGINAL HAEMORRHAGE |
3 |
0.0001 |
| 612 |
APATHY |
1 |
0.0001 |
| 613 |
COVID-19 |
12 |
0.0001 |
| 614 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
2 |
0.0001 |
| 615 |
URINARY INCONTINENCE |
2 |
0.0001 |
| 616 |
SKIN HAEMORRHAGE |
1 |
0.0001 |
| 617 |
COLON CANCER |
1 |
0.0001 |
| 618 |
GASTROINTESTINAL DISORDER |
6 |
0.0001 |
| 619 |
RESPIRATORY DISORDER |
2 |
0.0001 |
| 620 |
HOT FLUSH |
5 |
0.0001 |
| 621 |
HEPATIC FAILURE |
2 |
0.0001 |
| 622 |
SUICIDE ATTEMPT |
4 |
0.0001 |
| 623 |
OSTEOPENIA |
1 |
0.0001 |
| 624 |
DEVICE FAILURE |
1 |
0.0001 |
| 625 |
NEPHROLITHIASIS |
3 |
0.0001 |
| 626 |
LYMPHOMA |
1 |
0.0001 |
| 627 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 628 |
TENDONITIS |
1 |
0.0001 |
| 629 |
NAUSEA |
51 |
0.0001 |
| 630 |
BASAL CELL CARCINOMA |
1 |
0.0001 |
| 631 |
BRAIN FOG |
1 |
0.0001 |
| 632 |
CYANOSIS |
1 |
0.0001 |
| 633 |
ARTHRITIS |
5 |
0.0001 |
| 634 |
PAIN |
39 |
0.0001 |
| 635 |
DYSPHAGIA |
6 |
0.0001 |
| 636 |
HEAD INJURY |
2 |
0.0001 |
| 637 |
FALL |
21 |
0.0001 |
| 638 |
RESPIRATORY TRACT CONGESTION |
1 |
0.0001 |
| 639 |
WEIGHT INCREASED |
14 |
0.0001 |
| 640 |
INTENTIONAL OVERDOSE |
4 |
0.0001 |
| 641 |
CARDIAC FAILURE |
5 |
0.0001 |
| 642 |
RASH |
27 |
0.0001 |
| 643 |
LACTIC ACIDOSIS |
2 |
0.0001 |
| 644 |
MUSCULAR WEAKNESS |
7 |
0.0001 |
| 645 |
SWELLING FACE |
4 |
0.0001 |
| 646 |
LUNG DISORDER |
3 |
0.0001 |
| 647 |
IMPAIRED HEALING |
2 |
0.0001 |
| 648 |
VENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 649 |
HYPOAESTHESIA |
9 |
0.0001 |
| 650 |
COAGULOPATHY |
1 |
0.0001 |
| 651 |
ABDOMINAL DISCOMFORT |
10 |
0.0001 |
| 652 |
CELLULITIS |
3 |
0.0001 |
| 653 |
EYE PRURITUS |
2 |
0.0001 |
| 654 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0001 |
| 655 |
FACE OEDEMA |
1 |
0.0001 |
| 656 |
CANDIDA INFECTION |
1 |
0.0001 |
| 657 |
FLUID RETENTION |
3 |
0.0001 |
| 658 |
BLOOD PRESSURE INCREASED |
9 |
0.0001 |
| 659 |
URINARY TRACT INFECTION |
10 |
0.0001 |
| 660 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 661 |
OEDEMA PERIPHERAL |
7 |
0.0001 |
| 662 |
HEADACHE |
36 |
0.0001 |
| 663 |
NERVOUSNESS |
3 |
0.0001 |
| 664 |
RASH MACULAR |
2 |
0.0001 |
| 665 |
DEVICE MALFUNCTION |
4 |
0.0001 |
| 666 |
LYMPHOCYTE COUNT DECREASED |
1 |
0.0001 |
| 667 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
1 |
0.0001 |
| 668 |
LYMPHADENOPATHY |
2 |
0.0001 |
| 669 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 670 |
DRUG ERUPTION |
1 |
0.0001 |
| 671 |
GOUT |
1 |
0.0001 |
| 672 |
FATIGUE |
43 |
0.0001 |
| 673 |
BRONCHITIS |
4 |
0.0001 |
| 674 |
AGRANULOCYTOSIS |
1 |
0.0001 |
| 675 |
INFLUENZA |
6 |
0.0001 |
| 676 |
HEPATIC STEATOSIS |
1 |
0.0001 |
| 677 |
NECK PAIN |
3 |
0.0001 |
| 678 |
PANCYTOPENIA |
3 |
0.0001 |
| 679 |
HEPATIC FUNCTION ABNORMAL |
2 |
0.0001 |
| 680 |
MIDDLE INSOMNIA |
1 |
0.0001 |
| 681 |
ABDOMINAL PAIN UPPER |
11 |
0.0001 |
| 682 |
SWELLING |
5 |
0.0001 |
| 683 |
HEPATIC CIRRHOSIS |
1 |
0.0001 |
| 684 |
CEREBROVASCULAR ACCIDENT |
9 |
0.0001 |
| 685 |
FLATULENCE |
3 |
0.0001 |
| 686 |
FRACTURE |
1 |
0.0001 |
| 687 |
GASTRIC ULCER |
1 |
0.0001 |
| 688 |
PROTEINURIA |
1 |
0.0001 |
| 689 |
LETHARGY |
3 |
0.0001 |
| 690 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 691 |
SEROTONIN SYNDROME |
1 |
0.0001 |
| 692 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 693 |
SEIZURE |
6 |
0.0001 |
| 694 |
DRUG INTOLERANCE |
5 |
0.0001 |
| 695 |
DYSPHONIA |
3 |
0.0001 |
| 696 |
CHOKING |
1 |
0.0001 |
| 697 |
BONE PAIN |
3 |
0.0001 |
| 698 |
SURGERY |
3 |
0.0001 |
| 699 |
SINUS DISORDER |
1 |
0.0001 |
| 700 |
DISORIENTATION |
2 |
0.0001 |
| 701 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 702 |
PRESCRIBED UNDERDOSE |
1 |
0.0001 |
| 703 |
FULL BLOOD COUNT DECREASED |
1 |
0.0000 |
| 704 |
VERTIGO |
3 |
0.0000 |
| 705 |
FOETAL EXPOSURE DURING PREGNANCY |
4 |
0.0000 |
| 706 |
PRODUCT PREPARATION ERROR |
1 |
0.0000 |
| 707 |
ERYTHEMA |
10 |
0.0000 |
| 708 |
RIB FRACTURE |
1 |
0.0000 |
| 709 |
INJECTION SITE WARMTH |
1 |
0.0000 |
| 710 |
INFECTION |
7 |
0.0000 |
| 711 |
TREMOR |
8 |
0.0000 |
| 712 |
ARTHRALGIA |
20 |
0.0000 |
| 713 |
RHABDOMYOLYSIS |
2 |
0.0000 |
| 714 |
MALAISE |
21 |
0.0000 |
| 715 |
ASTHENIA |
18 |
0.0000 |
| 716 |
JOINT INJURY |
1 |
0.0000 |
| 717 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 718 |
DIARRHOEA |
30 |
0.0000 |
| 719 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 720 |
SKIN CANCER |
1 |
0.0000 |
| 721 |
FAECES DISCOLOURED |
1 |
0.0000 |
| 722 |
SEPTIC SHOCK |
2 |
0.0000 |
| 723 |
INTERVERTEBRAL DISC PROTRUSION |
1 |
0.0000 |
| 724 |
ANGIOEDEMA |
2 |
0.0000 |
| 725 |
STEVENS-JOHNSON SYNDROME |
1 |
0.0000 |
| 726 |
TRANSAMINASES INCREASED |
1 |
0.0000 |
| 727 |
THROMBOCYTOPENIA |
5 |
0.0000 |
| 728 |
PULMONARY OEDEMA |
2 |
0.0000 |
| 729 |
ORAL PAIN |
1 |
0.0000 |
| 730 |
RASH PAPULAR |
1 |
0.0000 |
| 731 |
SNEEZING |
1 |
0.0000 |
| 732 |
PARAESTHESIA |
7 |
0.0000 |
| 733 |
CHROMATURIA |
1 |
0.0000 |
| 734 |
HEART RATE IRREGULAR |
1 |
0.0000 |
| 735 |
MUSCLE SPASMS |
8 |
0.0000 |
| 736 |
TINNITUS |
2 |
0.0000 |
| 737 |
HYPOKALAEMIA |
2 |
0.0000 |
| 738 |
GENERAL PHYSICAL HEALTH DETERIORATION |
5 |
0.0000 |
| 739 |
OROPHARYNGEAL PAIN |
4 |
0.0000 |
| 740 |
BACK PAIN |
10 |
0.0000 |
| 741 |
COUGH |
12 |
0.0000 |
| 742 |
PALPITATIONS |
5 |
0.0000 |
| 743 |
SLEEP DISORDER |
3 |
0.0000 |
| 744 |
HYPERTENSION |
9 |
0.0000 |
| 745 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
3 |
0.0000 |
| 746 |
COMA |
2 |
0.0000 |
| 747 |
PRODUCTIVE COUGH |
2 |
0.0000 |
| 748 |
BLOOD PRESSURE FLUCTUATION |
1 |
0.0000 |
| 749 |
JOINT SWELLING |
5 |
0.0000 |
| 750 |
FIBROMYALGIA |
1 |
0.0000 |
| 751 |
UNDERDOSE |
3 |
0.0000 |
| 752 |
LIVER INJURY |
1 |
0.0000 |
| 753 |
DYSPEPSIA |
4 |
0.0000 |
| 754 |
MYOCARDIAL INFARCTION |
7 |
0.0000 |
| 755 |
EPISTAXIS |
3 |
0.0000 |
| 756 |
PNEUMONIA ASPIRATION |
1 |
0.0000 |
| 757 |
SYNCOPE |
4 |
0.0000 |
| 758 |
UNEVALUABLE EVENT |
3 |
0.0000 |
| 759 |
ACNE |
3 |
0.0000 |
| 760 |
CHRONIC KIDNEY DISEASE |
3 |
0.0000 |
| 761 |
GASTRIC CANCER |
1 |
0.0000 |
| 762 |
PRODUCT COMPLAINT |
1 |
0.0000 |
| 763 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 764 |
UNRESPONSIVE TO STIMULI |
1 |
0.0000 |
| 765 |
ANXIETY |
11 |
0.0000 |
| 766 |
EXPOSURE VIA SKIN CONTACT |
1 |
0.0000 |
| 767 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
2 |
0.0000 |
| 768 |
ABDOMINAL DISTENSION |
4 |
0.0000 |
| 769 |
DEAFNESS |
1 |
0.0000 |
| 770 |
SPEECH DISORDER |
2 |
0.0000 |
| 771 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
1 |
0.0000 |
| 772 |
PANCREATITIS |
2 |
0.0000 |
| 773 |
DRUG INTERACTION |
6 |
0.0000 |
| 774 |
CHEST PAIN |
7 |
0.0000 |
| 775 |
EAR INFECTION |
1 |
0.0000 |
| 776 |
DEHYDRATION |
5 |
0.0000 |
| 777 |
THROMBOSIS |
3 |
0.0000 |
| 778 |
THROAT TIGHTNESS |
1 |
0.0000 |
| 779 |
OFF LABEL USE |
32 |
0.0000 |
| 780 |
DEVICE DELIVERY SYSTEM ISSUE |
1 |
0.0000 |
| 781 |
DIVERTICULITIS |
1 |
0.0000 |
| 782 |
OXYGEN SATURATION DECREASED |
2 |
0.0000 |
| 783 |
ASTHMA |
4 |
0.0000 |
| 784 |
PRODUCT DOSE OMISSION IN ERROR |
1 |
0.0000 |
| 785 |
PAIN IN JAW |
1 |
0.0000 |
| 786 |
MYALGIA |
6 |
0.0000 |
| 787 |
INTENTIONAL DOSE OMISSION |
1 |
0.0000 |
| 788 |
PRODUCT SUBSTITUTION ISSUE |
2 |
0.0000 |
| 789 |
ABDOMINAL PAIN |
8 |
0.0000 |
| 790 |
PAIN IN EXTREMITY |
10 |
0.0000 |
| 791 |
TACHYCARDIA |
3 |
0.0000 |
| 792 |
RENAL INJURY |
1 |
0.0000 |
| 793 |
DEVICE ISSUE |
3 |
0.0000 |
| 794 |
PREMATURE BABY |
1 |
0.0000 |
| 795 |
APHASIA |
1 |
0.0000 |
| 796 |
STOMATITIS |
2 |
0.0000 |
| 797 |
PLEURAL EFFUSION |
2 |
0.0000 |
| 798 |
EPILEPSY |
1 |
0.0000 |
| 799 |
FEELING HOT |
2 |
0.0000 |
| 800 |
ALANINE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 801 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 802 |
DYSPNOEA |
18 |
0.0000 |
| 803 |
MOOD SWINGS |
1 |
0.0000 |
| 804 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 805 |
HIP FRACTURE |
1 |
0.0000 |
| 806 |
NIGHT SWEATS |
1 |
0.0000 |
| 807 |
ATRIAL FIBRILLATION |
3 |
0.0000 |
| 808 |
FEBRILE NEUTROPENIA |
2 |
0.0000 |
| 809 |
VISUAL ACUITY REDUCED |
1 |
0.0000 |
| 810 |
INSOMNIA |
8 |
0.0000 |
| 811 |
FUNGAL INFECTION |
1 |
0.0000 |
| 812 |
SKIN DISORDER |
1 |
0.0000 |
| 813 |
TYPE 2 DIABETES MELLITUS |
1 |
0.0000 |
| 814 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
0.0000 |
| 815 |
FLUSHING |
3 |
0.0000 |
| 816 |
GASTRIC DISORDER |
1 |
0.0000 |
| 817 |
HYPERKALAEMIA |
1 |
0.0000 |
| 818 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
1 |
0.0000 |
| 819 |
PLATELET COUNT DECREASED |
3 |
0.0000 |
| 820 |
THERAPY INTERRUPTED |
2 |
0.0000 |
| 821 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 822 |
PNEUMONIA |
9 |
0.0000 |
| 823 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 824 |
RESTLESSNESS |
1 |
0.0000 |
| 825 |
NASOPHARYNGITIS |
5 |
0.0000 |
| 826 |
DYSGEUSIA |
2 |
0.0000 |
| 827 |
PRODUCT USE ISSUE |
5 |
0.0000 |
| 828 |
DYSARTHRIA |
1 |
0.0000 |
| 829 |
HALLUCINATION |
2 |
0.0000 |
| 830 |
ACUTE KIDNEY INJURY |
4 |
0.0000 |
| 831 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 832 |
PLASMA CELL MYELOMA |
1 |
0.0000 |
| 833 |
ABORTION SPONTANEOUS |
1 |
0.0000 |
| 834 |
CONFUSIONAL STATE |
4 |
0.0000 |
| 835 |
NEUTROPHIL COUNT DECREASED |
1 |
0.0000 |
| 836 |
INFLUENZA LIKE ILLNESS |
2 |
0.0000 |
| 837 |
TREATMENT FAILURE |
2 |
0.0000 |
| 838 |
WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 839 |
SKIN EXFOLIATION |
2 |
0.0000 |
| 840 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 841 |
RECTAL HAEMORRHAGE |
1 |
0.0000 |
| 842 |
MENTAL DISORDER |
1 |
0.0000 |
| 843 |
INTENTIONAL PRODUCT MISUSE |
2 |
0.0000 |
| 844 |
DRY SKIN |
3 |
0.0000 |
| 845 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 846 |
ADVERSE DRUG REACTION |
2 |
0.0000 |
| 847 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 848 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 849 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 850 |
BREAST CANCER |
2 |
0.0000 |
| 851 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 852 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
1 |
0.0000 |
| 853 |
ARRHYTHMIA |
1 |
0.0000 |
| 854 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 855 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 856 |
RENAL CANCER |
1 |
0.0000 |
| 857 |
ANAEMIA |
4 |
0.0000 |
| 858 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 859 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 860 |
INTERSTITIAL LUNG DISEASE |
1 |
0.0000 |
| 861 |
ALOPECIA |
4 |
0.0000 |
| 862 |
PRODUCT USE IN UNAPPROVED INDICATION |
5 |
0.0000 |
| 863 |
LEUKOPENIA |
1 |
0.0000 |
| 864 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 865 |
HAEMOGLOBIN DECREASED |
2 |
0.0000 |
| 866 |
ECZEMA |
1 |
0.0000 |
| 867 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 868 |
RASH PRURITIC |
1 |
0.0000 |
| 869 |
WHITE BLOOD CELL COUNT DECREASED |
2 |
0.0000 |
| 870 |
TREATMENT NONCOMPLIANCE |
1 |
0.0000 |
| 871 |
HYPONATRAEMIA |
1 |
0.0000 |
| 872 |
DEPRESSION |
4 |
0.0000 |
| 873 |
CHILLS |
2 |
0.0000 |
| 874 |
IRRITABILITY |
1 |
0.0000 |
| 875 |
NO ADVERSE EVENT |
3 |
0.0000 |
| 876 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 877 |
RHINORRHOEA |
1 |
0.0000 |
| 878 |
AMNESIA |
1 |
0.0000 |
| 879 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 880 |
PSORIASIS |
2 |
0.0000 |
| 881 |
DEATH |
13 |
0.0000 |
| 882 |
RENAL FAILURE |
2 |
0.0000 |
| 883 |
HYPOTENSION |
3 |
0.0000 |
| 884 |
NEUTROPENIA |
2 |
0.0000 |
| 885 |
PYREXIA |
5 |
0.0000 |
| 886 |
INJURY |
1 |
0.0000 |
| 887 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 888 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 889 |
AGITATION |
1 |
0.0000 |
| 890 |
HOSPITALISATION |
2 |
0.0000 |
| 891 |
DRUG DOSE OMISSION BY DEVICE |
1 |
0.0000 |
| 892 |
PROSTATE CANCER |
1 |
0.0000 |
| 893 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 894 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 895 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 896 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 897 |
CARDIAC DISORDER |
1 |
0.0000 |
| 898 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 899 |
RHEUMATOID ARTHRITIS |
1 |
0.0000 |
| 900 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 901 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 902 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 903 |
CONDITION AGGRAVATED |
2 |
0.0000 |